Login / Signup

Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab.

Motoo NomuraAtsushi OtsukaTomohiro KondoHiroki NagaiYumi NonomuraYo KakuShigemi MatsumotoManabu Muto
Published in: Cancer chemotherapy and pharmacology (2017)
This study showed that retreatment with nivolumab is an option for select metastatic melanoma patients after previous nivolumab treatment.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • combination therapy
  • smoking cessation